Literature DB >> 16631752

A kinase independent function for Tec kinase ITK in regulating antigen receptor induced serum response factor activation.

Shengli Hao1, Qian Qi, Jianfang Hu, Avery August.   

Abstract

The Tec family kinases are critical downstream regulators of antigen receptor signals in lymphocytes. As kinases, they act on critical substrates to regulate signals such as calcium increase leading to activation of transcription factors such as NFAT, NFkappaB and SRF. We now show here that ITK, a member of the Tec family of tyrosine kinases, has a kinase independent function. Mutants of ITK that lack kinase activity or a kinase domain can rescue cells lacking Tec family kinases for antigen receptor induced SRF activation, but not for NFAT, AP-1 or NFkappaB activation. Furthermore, expression of these mutants in WT cells enhanced SRF activation. This kinase independent function required the SH2 domain since a mutant lacking both the kinase and SH2 domains was much less effective at rescuing SRF activation. This kinase-deleted mutant could partially rescue ERK activation, and interact with multiple tyrosine phosphorylated proteins during antigen receptor signaling, suggesting that ITK uses a scaffolding function that regulates signals leading to specific regulation of SRF activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631752     DOI: 10.1016/j.febslet.2006.04.023

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  T-cell signaling regulated by the Tec family kinase, Itk.

Authors:  Amy H Andreotti; Pamela L Schwartzberg; Raji E Joseph; Leslie J Berg
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

2.  Interleukin-2-inducible T cell kinase (Itk) network edge dependence for the maturation of iNKT cell.

Authors:  Qian Qi; Mingcan Xia; Yuting Bai; Sanhong Yu; Margherita Cantorna; Avery August
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

3.  The Tec family kinase Itk exists as a folded monomer in vivo.

Authors:  Qian Qi; Avery August
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

4.  Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.

Authors:  Wenchang Guo; Ruiwu Liu; Yoko Ono; Ai-Hong Ma; Anthony Martinez; Eduardo Sanchez; Yan Wang; Wenzhe Huang; Anisha Mazloom; Jixian Li; Jinying Ning; Emanual Maverakis; Kit S Lam; Hsing-Jien Kung
Journal:  Mol Pharmacol       Date:  2012-08-16       Impact factor: 4.436

5.  TCR/ITK Signaling in Type 1 Regulatory T cells.

Authors:  Michael C McGee; Avery August; Weishan Huang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  The zinc-binding region of IL-2 inducible T cell kinase (Itk) is required for interaction with Gα13 and activation of serum response factor.

Authors:  Weishan Huang; J Luis Morales; Victor P Gazivoda; Jianbin Lai; Qian Qi; Avery August
Journal:  Int J Biochem Cell Biol       Date:  2013-02-27       Impact factor: 5.085

7.  Selective targeting of ITK blocks multiple steps of HIV replication.

Authors:  Julie A Readinger; Gillian M Schiralli; Jian-Kang Jiang; Craig J Thomas; Avery August; Andrew J Henderson; Pamela L Schwartzberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

8.  Memory phenotype CD8+ T cells with innate function selectively develop in the absence of active Itk.

Authors:  Jianfang Hu; Nisebita Sahu; Elizabeth Walsh; Avery August
Journal:  Eur J Immunol       Date:  2007-10       Impact factor: 5.532

9.  IL-2-inducible T-cell kinase (ITK) finds another (dance) partner...TFII-I.

Authors:  Avery August
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

Review 10.  ITK inhibitors in inflammation and immune-mediated disorders.

Authors:  Nisebita Sahu; Avery August
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.